366.7K
Downloads
255
Episodes
The Cardiovascular CME podcast is a free educational offering from Mayo Clinic, featuring content geared towards physicians, physician assistants, and nurse practitioners who are interested in exploring a multitude of cardiology-related topics. Tune in and subscribe to explore today’s most pressing cardiology topics with your colleagues at Mayo Clinic and gain valuable insights that can be directly applied to your practice. No CME credit offered for podcast episodes at this time.
Episodes
Tuesday Sep 28, 2021
Tuesday Sep 28, 2021
TTR Cardiac Amyloid - How Common and How to Diagnose
Guest: Omar F. Abou Ezzeddine, M.D., C.M., M.S. (@abouezzeddine)
Host: Paul A. Friedman, M.D. (@drpaulfriedman)
There are two main types of cardiac amyloidosis. One is a medical emergency involving light chain amyloid. The source of the amyloid is the bone marrow, which secretes excessive amounts of monoclonal protein that infiltrate the myocardium and cause an acute necrotic infiltrative and restrictive cardiomyopathy. In the second type, transthyretin (TTR) amyloidosis, the source of the protein is the liver. The course of TTR amyloidosis occurs over years.
Joining us today to discuss cardiac amyloidosis is Omar F. Abou Ezzeddine, M.D., C.M., M.S., a consultant in Cardiovascular Medicine and director of the Cardiac Sarcoid Clinic at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- Cardiac amyloidosis
- Signs and symptoms indicative of cardiac amyloidosis
- Patients who receive atrial fibrillation ablation and patients who receive transcatheter aortic valve replacement (TAVR)
- Tools for diagnosis, including pyrophosphate (PYP) and MRI scans
- Therapeutic options for patients with TTR amyloidosis, including tafamidis
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
No CME credit offered for this episode.
Podcast episode transcript found here.